Skip to main content
Top
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women’s health initiative

Authors: Jennifer L. Beebe-Dimmer, Cecilia Yee, Electra Paskett, Ann G. Schwartz, Dorothy Lane, Nynikka R. A. Palmer, Cathryn H. Bock, Rami Nassir, Michael S. Simon

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Evidence suggests that risk of colorectal and prostate cancer is increased among those with a family history of the same disease, particularly among first-degree relatives. However, the aggregation of colorectal and prostate cancer within families has not been well investigated.

Methods

Analyses were conducted among participants of the Women’s Health Initiative (WHI) observational cohort, free of cancer at the baseline examination. Subjects were followed for colorectal cancer through August 31st, 2009. A Cox-proportional hazards regression modeling approach was used to estimate risk of colorectal cancer associated with a family history of prostate cancer, colorectal cancer and both cancers among first-degree relatives of all participants and stratified by race (African American vs. White).

Results

Of 75,999 eligible participants, there were 1122 colorectal cancer cases diagnosed over the study period. A family history of prostate cancer alone was not associated with an increase in colorectal cancer risk after adjustment for confounders (aHR =0.94; 95% CI =0.76, 1.15). Separate analysis examining the joint impact, a family history of both colorectal and prostate cancer was associated with an almost 50% increase in colorectal cancer risk (aHR = 1.48; 95% CI = 1.04, 2.10), but similar to those with a family history of colorectal cancer only (95% CI = 1.31; 95% CI = 1.11, 1.54).

Conclusions

Our findings suggest risk of colorectal cancer is increased similarly among women with colorectal cancer only and among those with both colorectal and prostate cancer diagnosed among first-degree family members. Future studies are needed to determine the relative contribution of genes and shared environment to the risk of both cancers.
Literature
2.
go back to reference Stanford JL, Ostrander EA. Familial prostate cancer. EpidemiolRev. 2001;23:19–23. Stanford JL, Ostrander EA. Familial prostate cancer. EpidemiolRev. 2001;23:19–23.
3.
go back to reference Hayes RB, Liff JM, Pottern LM, et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer. 1995;60:361–4.CrossRefPubMed Hayes RB, Liff JM, Pottern LM, et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer. 1995;60:361–4.CrossRefPubMed
4.
go back to reference Slattery ML, Levin TR, Ma K, Goldgar D, Holubkov R, Edwards S. Family history and colorectal cancer: predictors of risk. Cancer Causes Control. 2003;14:879–87.CrossRefPubMed Slattery ML, Levin TR, Ma K, Goldgar D, Holubkov R, Edwards S. Family history and colorectal cancer: predictors of risk. Cancer Causes Control. 2003;14:879–87.CrossRefPubMed
5.
go back to reference Baglietto L, Jenkins MA, Severi G, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. JClinEpidemiol. 2006;59:114–24. Baglietto L, Jenkins MA, Severi G, et al. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. JClinEpidemiol. 2006;59:114–24.
7.
go back to reference Schoen RE, Razzak A, KJ Y, et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology. 2015; Schoen RE, Razzak A, KJ Y, et al. Incidence and mortality of colorectal cancer in individuals with a family history of colorectal cancer. Gastroenterology. 2015;
8.
go back to reference Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis. PLoS.One. 2011;6:e27130.CrossRefPubMedPubMedCentral Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis. PLoS.One. 2011;6:e27130.CrossRefPubMedPubMedCentral
9.
go back to reference Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N.Engl.J.Med. 1994;331:1669–74.CrossRefPubMed Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N.Engl.J.Med. 1994;331:1669–74.CrossRefPubMed
10.
go back to reference Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer. 2003;97:1894–903.CrossRefPubMed Zeegers MP, Jellema A, Ostrer H. Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer. 2003;97:1894–903.CrossRefPubMed
11.
go back to reference Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int. J Cancer. 2003;107:797–803.CrossRefPubMed Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int. J Cancer. 2003;107:797–803.CrossRefPubMed
12.
go back to reference Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur. J Cancer. 2006;42:216–27.CrossRefPubMed Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur. J Cancer. 2006;42:216–27.CrossRefPubMed
13.
go back to reference Samadder NJ, Jasperson K, Burt RW. Hereditary and common familial colorectal cancer: evidence for colorectal screening. DigDisSci. 2015;60:734–47. Samadder NJ, Jasperson K, Burt RW. Hereditary and common familial colorectal cancer: evidence for colorectal screening. DigDisSci. 2015;60:734–47.
14.
go back to reference Stoffel EM. Screening in GI cancers: the role of genetics. J.Clin Oncologia. 2015;33:1721–8.CrossRef Stoffel EM. Screening in GI cancers: the role of genetics. J.Clin Oncologia. 2015;33:1721–8.CrossRef
17.
go back to reference Xu J, Lange EM, Lu L, et al. HOXB13 is a susceptibility gene for prostate cancer: results from the international consortium for prostate cancer genetics (ICPCG). HumGenet. 2012; Xu J, Lange EM, Lu L, et al. HOXB13 is a susceptibility gene for prostate cancer: results from the international consortium for prostate cancer genetics (ICPCG). HumGenet. 2012;
18.
go back to reference Kirchhoff T, Kauff ND, Mitra N, et al. BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res. 2004;10:2918–21.CrossRefPubMed Kirchhoff T, Kauff ND, Mitra N, et al. BRCA mutations and risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res. 2004;10:2918–21.CrossRefPubMed
19.
go back to reference Gallagher DJ, Gaudet MM, Pal P, et al. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res. 2010;16:2115–21.CrossRefPubMedPubMedCentral Gallagher DJ, Gaudet MM, Pal P, et al. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res. 2010;16:2115–21.CrossRefPubMedPubMedCentral
20.
go back to reference Carter BS, Carter HB, Isaacs JT. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate. 1990;16:187–97.CrossRefPubMed Carter BS, Carter HB, Isaacs JT. Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate. 1990;16:187–97.CrossRefPubMed
21.
go back to reference Turati F, Edefonti V, Bosetti C, et al. Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncologia. 2013;24:2651–6.CrossRef Turati F, Edefonti V, Bosetti C, et al. Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncologia. 2013;24:2651–6.CrossRef
22.
go back to reference Zeegers MP, Schouten LJ, Goldbohm RA, van den Brandt PAA. Compendium of familial relative risks of cancer among first degree relatives: a population-based study. Int. J Cancer. 2008;123:1664–73.CrossRefPubMed Zeegers MP, Schouten LJ, Goldbohm RA, van den Brandt PAA. Compendium of familial relative risks of cancer among first degree relatives: a population-based study. Int. J Cancer. 2008;123:1664–73.CrossRefPubMed
23.
go back to reference Hemminki K, Chen B. Familial association of colorectal adenocarcinoma with cancers at other sites. Eur. J Cancer. 2004;40:2480–7.CrossRefPubMed Hemminki K, Chen B. Familial association of colorectal adenocarcinoma with cancers at other sites. Eur. J Cancer. 2004;40:2480–7.CrossRefPubMed
24.
go back to reference Brandt A, Sundquist J, Hemminki K. Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer. Ann Oncologia. 2012;23:251–6.CrossRef Brandt A, Sundquist J, Hemminki K. Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer. Ann Oncologia. 2012;23:251–6.CrossRef
25.
go back to reference Jang JH, Cotterchio M, Gallinger S, Knight JA, Daftary D. Family history of hormonal cancers and colorectal cancer risk: a case-control study conducted in Ontario. Int.J Cancer. 2009;125:918–25.CrossRefPubMedPubMedCentral Jang JH, Cotterchio M, Gallinger S, Knight JA, Daftary D. Family history of hormonal cancers and colorectal cancer risk: a case-control study conducted in Ontario. Int.J Cancer. 2009;125:918–25.CrossRefPubMedPubMedCentral
26.
go back to reference Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: the Utah population database. J Natl Cancer Inst. 1994;86:1618–26.CrossRefPubMed Slattery ML, Kerber RA. Family history of cancer and colon cancer risk: the Utah population database. J Natl Cancer Inst. 1994;86:1618–26.CrossRefPubMed
27.
go back to reference Desantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer JClin. 2013;63:151–66.CrossRef Desantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer JClin. 2013;63:151–66.CrossRef
28.
go back to reference Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Gastroenterology. 2017;153:307–23.CrossRefPubMed Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Gastroenterology. 2017;153:307–23.CrossRefPubMed
29.
go back to reference Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women’s Health Initiative observational study: baseline characteristics of participants and reliability of baseline measures. AnnEpidemiol. 2003;13:S107–21. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women’s Health Initiative observational study: baseline characteristics of participants and reliability of baseline measures. AnnEpidemiol. 2003;13:S107–21.
30.
go back to reference Hays J, Hunt JR, Hubbell FA, et al. The Women’s Health Initiative recruitment methods and results. Ann.Epidemiol. 2003;13:S18–77.CrossRefPubMed Hays J, Hunt JR, Hubbell FA, et al. The Women’s Health Initiative recruitment methods and results. Ann.Epidemiol. 2003;13:S18–77.CrossRefPubMed
31.
go back to reference Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group. Control Clin. Trials 1998;19:61–109. Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group. Control Clin. Trials 1998;19:61–109.
32.
go back to reference Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women’s Health Initiative. Ann.Epidemiol. 2003;13:S122–8.CrossRefPubMed Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women’s Health Initiative. Ann.Epidemiol. 2003;13:S122–8.CrossRefPubMed
33.
go back to reference Beebe-Dimmer JL, Yee C, Cote M, et al. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women’s Health Initiative study. Cancer. 2014; Beebe-Dimmer JL, Yee C, Cote M, et al. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women’s Health Initiative study. Cancer. 2014;
35.
go back to reference Stoffel E, Mukherjee B, Raymond VM, et al. Calculation of risk of colorectal and endometrial cancer among patients with lynch syndrome. Gastroenterology. 2009;137:1621–7.CrossRefPubMedPubMedCentral Stoffel E, Mukherjee B, Raymond VM, et al. Calculation of risk of colorectal and endometrial cancer among patients with lynch syndrome. Gastroenterology. 2009;137:1621–7.CrossRefPubMedPubMedCentral
36.
go back to reference Almario CV, May FP, Ponce NA, Spiegel BM. Racial and ethnic disparities in Colonoscopic examination of individuals with a family history of colorectal cancer. ClinGastroenterolHepatol. 2015;13:1487–95. Almario CV, May FP, Ponce NA, Spiegel BM. Racial and ethnic disparities in Colonoscopic examination of individuals with a family history of colorectal cancer. ClinGastroenterolHepatol. 2015;13:1487–95.
37.
go back to reference Ait OD, Lockett T, Boussioutas A, Hopper JL, Jenkins MA. Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Fam Cancer. 2013;12:459–72.CrossRef Ait OD, Lockett T, Boussioutas A, Hopper JL, Jenkins MA. Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Fam Cancer. 2013;12:459–72.CrossRef
38.
go back to reference Hall MJ, Ruth K, Giri VN. Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program. Cancer. 2012;118:478–84.CrossRefPubMed Hall MJ, Ruth K, Giri VN. Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program. Cancer. 2012;118:478–84.CrossRefPubMed
39.
go back to reference Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292:1480–9.CrossRefPubMed Murff HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA. 2004;292:1480–9.CrossRefPubMed
Metadata
Title
Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women’s health initiative
Authors
Jennifer L. Beebe-Dimmer
Cecilia Yee
Electra Paskett
Ann G. Schwartz
Dorothy Lane
Nynikka R. A. Palmer
Cathryn H. Bock
Rami Nassir
Michael S. Simon
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3873-5

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine